Your browser doesn't support javascript.
loading
Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host.
Meisel, Marlies; Hinterleitner, Reinhard; Pacis, Alain; Chen, Li; Earley, Zachary M; Mayassi, Toufic; Pierre, Joseph F; Ernest, Jordan D; Galipeau, Heather J; Thuille, Nikolaus; Bouziat, Romain; Buscarlet, Manuel; Ringus, Daina L; Wang, Yitang; Li, Ye; Dinh, Vu; Kim, Sangman M; McDonald, Benjamin D; Zurenski, Matthew A; Musch, Mark W; Furtado, Glaucia C; Lira, Sergio A; Baier, Gottfried; Chang, Eugene B; Eren, A Murat; Weber, Christopher R; Busque, Lambert; Godley, Lucy A; Verdú, Elena F; Barreiro, Luis B; Jabri, Bana.
Afiliación
  • Meisel M; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Hinterleitner R; Committee on Immunology, University of Chicago, Chicago, IL, USA.
  • Pacis A; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Chen L; Committee on Immunology, University of Chicago, Chicago, IL, USA.
  • Earley ZM; Department of Genetics, CHU Sainte-Justine Research Center, Montreal, Quebec, Canada.
  • Mayassi T; Department of Biochemistry, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.
  • Pierre JF; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Ernest JD; Committee on Immunology, University of Chicago, Chicago, IL, USA.
  • Galipeau HJ; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Thuille N; Committee on Immunology, University of Chicago, Chicago, IL, USA.
  • Bouziat R; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Buscarlet M; Committee on Immunology, University of Chicago, Chicago, IL, USA.
  • Ringus DL; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Wang Y; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA.
  • Li Y; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Dinh V; Committee on Immunology, University of Chicago, Chicago, IL, USA.
  • Kim SM; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • McDonald BD; Translational Cell Genetics, Department for Pharmacology and Genetics, Medical University of Innsbruck, Innsbruck, Austria.
  • Zurenski MA; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Musch MW; Committee on Immunology, University of Chicago, Chicago, IL, USA.
  • Furtado GC; Research Centre, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada.
  • Lira SA; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Baier G; Department of Pathology and Pediatrics, University of Chicago, Chicago, IL, USA.
  • Chang EB; Department of Pathology and Pediatrics, University of Chicago, Chicago, IL, USA.
  • Eren AM; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Weber CR; Committee on Immunology, University of Chicago, Chicago, IL, USA.
  • Busque L; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Godley LA; Committee on Immunology, University of Chicago, Chicago, IL, USA.
  • Verdú EF; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Barreiro LB; Department of Pathology and Pediatrics, University of Chicago, Chicago, IL, USA.
  • Jabri B; Department of Medicine, University of Chicago, Chicago, IL, USA.
Nature ; 557(7706): 580-584, 2018 05.
Article en En | MEDLINE | ID: mdl-29769727
ABSTRACT
Somatic mutations in tet methylcytosine dioxygenase 2 (TET2), which encodes an epigenetic modifier enzyme, drive the development of haematopoietic malignancies1-7. In both humans and mice, TET2 deficiency leads to increased self-renewal of haematopoietic stem cells with a net developmental bias towards the myeloid lineage1,4,8,9. However, pre-leukaemic myeloproliferation (PMP) occurs in only a fraction of Tet2-/- mice8,9 and humans with TET2 mutations1,3,5-7, suggesting that extrinsic non-cell-autonomous factors are required for disease onset. Here we show that bacterial translocation and increased interleukin-6 production, resulting from dysfunction of the small-intestinal barrier, are critical for the development of PMP in mice that lack Tet2 expression in haematopoietic cells. Furthermore, in symptom-free Tet2-/- mice, PMP can be induced by disrupting intestinal barrier integrity, or in response to systemic bacterial stimuli such as the toll-like receptor 2 agonist. PMP was reversed by antibiotic treatment and failed to develop in germ-free Tet2-/- mice, which illustrates the importance of microbial signals in the development of this condition. Our findings demonstrate the requirement for microbial-dependent inflammation in the development of PMP and provide a mechanistic basis for the variation in PMP penetrance observed in Tet2-/- mice. This study will prompt new lines of investigation that may profoundly affect the prevention and management of haematopoietic malignancies.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia / Proteínas Proto-Oncogénicas / Fenómenos Fisiológicos Bacterianos / Proliferación Celular / Proteínas de Unión al ADN / Enfermedades Asintomáticas Límite: Animals Idioma: En Revista: Nature Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia / Proteínas Proto-Oncogénicas / Fenómenos Fisiológicos Bacterianos / Proliferación Celular / Proteínas de Unión al ADN / Enfermedades Asintomáticas Límite: Animals Idioma: En Revista: Nature Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos